Skip to main content

Market Overview

Jon Najarian Sees Unusual Option Activity In Target And Teva


On CNBC's "Fast Money Halftime Report," Jon Najarian gave some unusual option activity plays.

Najarian sees unusual activity in Target (NYSE: TGT) February $185 calls and Teva Pharmaceuticals (NYSE: TEVA) February $12 calls.

Najarian has a position in both of these and will hold for two to three weeks.


Related Articles (TEVA + TGT)

View Comments and Join the Discussion!

Posted-In: CNBC Jon NajarianOptions Markets Media

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at